Target intelligence / Profile preview

Iron-responsive element in the 5'-untranslated region of neurotoxic protein mRNAs (5'-UTR IRE)

Target
5'-UTR IRE
Molecular classification
RNA regulatory element, Non-coding RNA structure
01

Overview

The Iron-responsive element (IRE) is a highly conserved RNA stem-loop structure located in the 5'-untranslated region (UTR) of mRNAs for several key neurotoxic proteins, most notably the Amyloid Precursor Protein (APP), alpha-synuclein (SNCA), and the Prion protein (PrP) (Rogers et al., 2002; Friedlich et al., 2007). These elements function as critical post-transcriptional regulators that coordinate protein synthesis with cellular iron availability. In the absence of sufficient iron, Iron Regulatory Proteins (IRP1 and IRP2) bind to the 5'-UTR IRE, creating a steric block that prevents the 43S pre-initiation complex from scanning the mRNA, thus inhibiting translation (Muckenthaler et al., 2017). In neurodegenerative conditions such as Alzheimer's and Parkinson's diseases, iron dyshomeostasis often leads to the pathological upregulation of these proteins. Therapeutic agents like Buntanetap (Posiphen) are designed to target these IRE structures or the IRE-IRP interaction to suppress the translation of neurotoxic species, thereby reducing the accumulation of amyloid plaques and Lewy bodies (Chen-Plotkin et al., 2022). This approach represents a novel strategy for disease modification by intervening at the level of protein production rather than clearance.

Other names
IRE stem-loop5'-UTR iron-responsive elementAPP 5'-UTR IRESNCA 5'-UTR IREPrP 5'-UTR IREIron-regulatory element
02

Mechanism of action

Small molecules bind to or stabilize the IRE-IRP complex or otherwise interfere with the 5'-UTR-mediated translation initiation to reduce the synthesis of neurotoxic proteins.

03

Biological functions

Post-transcriptional regulationIron homeostasisTranslation inhibitionmRNA stability regulation
04

Disease associations

Alzheimer's diseaseParkinson's diseaseNeurodegenerative diseasePrion diseaseAmyotrophic lateral sclerosis
05

Safety considerations

Potential disruption of systemic iron homeostasisOff-target inhibition of essential IRE-containing proteins such as ferritin or ferroportinGastrointestinal distressPotential for unintended effects on erythropoiesis
06

Interacting drugs

Buntanetap (Posiphen)

3 more in the full profile.

07

Biomarkers

Cerebrospinal fluid Amyloid-beta 42 levelsCerebrospinal fluid Alpha-synuclein levelsCerebrospinal fluid Tau protein levelsBrain iron concentration (via MRI)Ferritin levels

Beyond the preview

Go deeper on Iron-responsive element in the 5'-untranslated region of neurotoxic protein mRNAs (5'-UTR IRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-responsive element in the 5'-untranslated region of neurotoxic protein mRNAs (5'-UTR IRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call